comprehensive -WSS

comprehensive

author：fashion 2025-10-02 23:31:10 - browse：3

Adam's take main illustration — Molly Ferguson/STAT

This week, an encouraging turnaround for Ocular Therapeutix, a chat with Alnylam’s CEO defending changes to the HELIOS-B study and talking up its hypertension treatment, and quick takes on Amylyx and obesity stocks.

A Worst CEO gets some much-needed help

For most of last year, Ocular Therapeutix CEO Antony Mattessich promised shareholders that he was close to nailing down a lucrative pharma partnership that would pay for late-stage clinical trials of the company’s treatments for degenerative eye diseases. The deal never happened. I heard from many Ocular investors who were frustrated and angry about Mattesich’s poor job performance. He ended up earning a spot last year on my worst biopharma CEO list. It was an easy pick.

On Thursday, Ocular announced a meaningful “leadership update.” Mattessich is still the CEO, but let’s just say the company’s board decided to surround him with new executives and retinal experts with proven track records of getting stuff done.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： What drug price negotiations mean for Medicare Part D

hotspot

WSS

Snackable artificial intelligence, expert AI, and the pharma industry

Colonoscopy at 40? Study finds a possible benefit

Why Novartis is changing the name of its research labs

CDC concerned about possible undetected monkeypox spread in U.K.

Crinetics acromegaly drug succeeds in late

Weight bias in eating disorder treatment complicated by new weight loss drugs

knowledge

comprehensive

A Worst CEO gets some much-needed help

Wikipedia

In age of alternative facts, a scholarly course on calling out crap

Medicaid rebukes states for mistakenly disenrolling children

Medical leaders decry Supreme Court decision on affirmative action

New guidelines on severe brain injury complicate already difficult decisions

Peter Hotez and the public health issue of online harassment

Stem cell treatment guidelines are released by FDA

ChatGPT in medicine: STAT answers readers' burning questions

Weight bias in eating disorder treatment complicated by new weight loss drugs

Walensky prepares to leave CDC — and Congress — behind

How to protect patients from sexual assault

hotspot

Ask STAT: What do you want to know about ChatGPT in medicine?

A rare thyroid diagnosis led to unexpected, all

Death of patient in Alzheimer’s trial raises question of possible risks

The science behind Janet Jackson's pregnancy at 49

Do masks work? RCTs can't tell us

The battle over the Brookhaven Landfill on Long Island

focus

hotspot

hotspot

focus